Icon

NEUPRO (nda021829)- (1MG/24HR,2MG/24HR,3MG/24HR,4MG/24HR,6MG/24HR,8MG/24HR)

ROTIGOTINE UCB INC
1MG/24HR,2MG/24HR,3MG/24HR,4MG/24HR,6MG/24HR,8MG/24HR
Yes No
2032-Mar-01 2012-May-09
None None
None No
NEUPRO is a dopamine agonist indicated for the treatment of: • Parkinson’s disease • Moderate-to-severe primary Restless Legs Syndrome
0 1 0
Total Other Developers 6
Drugs with Suitability No
1MG/24HR ** ** Up - -
2MG/24HR ** ** Up - -
3MG/24HR ** ** Up - -
4MG/24HR ** ** Up - -
6MG/24HR ** ** Up - -
8MG/24HR ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.